MKM. Yu. Kit

M. Yu. Kit

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


M. Yu. Kit has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Development of technical parameters for PCR to detect the blaNDM antibiotic resistance gene in Enterobacterales isolates and clinical samples

    by P. S. Yurko, T. B. Didyk, O. B. Zlenko, M. Yu. Kit

    Microbial resistance to antibiotics is one of the most pressing issues of our time. Among these resistance genes, the genes for resistance to β lactams, particularly the relatively new New Delhi metallo β lactamase (blaNDM) gene, are of particular note. The increasing prevalence of the blaNDM gene among pathogens causing hospital and poultry/livestock infections indicates the need for constant monitoring of its presence in microorganisms. This article describes the process of developing PCR parameters to detect the blaNDM gene. The optimal annealing temperature was determined to be 62 °C with 40 cycles using the T 3000 “Biometra” amplifier. Preliminary validation tests showed the method had a high level of analytical sensitivity, specificity, repeatability, and reproducibility. This method will effectively detect the blaNDM gene in microbial strains and clinical material

  • Open Access

    A rigorous benchmarking of methods for SARS-CoV-2 lineage abundance estimation in wastewater

    by Viorel Munteanu, Victor Gordeev, Michael Saldana, Eva Aßmann, Justin Maine Su, Nicolae Drabcinski, Oksana Zlenko, Maryna Kit, Felicia Iordachi, Khooshbu Kantibhai Patel, et al.

    In light of the continuous transmission and evolution of SARS-CoV-2 coupled with a significant decline in clinical testing, there is a pressing need for scalable, cost-effective, long-term, passive surveillance tools to effectively monitor viral variants circulating in the population. Wastewater genomic surveillance of SARS-CoV-2 has arrived as an alternative to clinical genomic surveillance, allowing to continuously monitor the prevalence of viral lineages in communities of various size at a fraction of the time, cost, and logistic effort and serving as an early warning system for emerging variants, critical for developed communities and especially for underserved ones. Importantly, lineage prevalence estimates obtained with this approach aren't distorted by biases related to clinical testing accessibility and participation. However, the relative performance of bioinformatics methods used to measure relative lineage abundances from wastewater sequencing data is unknown, preventing both the research community and public health authorities from making informed decisions regarding computational tool selection. Here, we perform comprehensive benchmarking of 18 bioinformatics methods for estimating the relative abundance of SARS-CoV-2 (sub)lineages in wastewater by using data from 36 in vitro mixtures of synthetic lineage and sublineage genomes. In addition, we use simulated data from 78 mixtures of lineages and sublineages co-occurring in the clinical setting with proportions mirroring their prevalence ratios observed in real data. Importantly, we investigate how the accuracy of the evaluated methods is impacted by the sequencing technology used, the associated error rate, the read length, read depth, but also by the exposure of the synthetic RNA mixtures to wastewater, with the goal of capturing the effects induced by the wastewater matrix, including RNA fragmentation and degradation.


  • Open Access

    Development of recombinant antigen expression and purification for African swine fever serological diagnostics

    by M. Yu. Kit

    The paper reports the purification and its optimization of recombinant proteins p10, p32, p54, p54ΔTM, DNA ligase and DNA ligaseΔDBD of African swine fever virus. The corresponding coding sequences were subcloned into pASG-IBA105 and pASG-IBA103 vectors, multiplied and used for transformation of competent E. coli expression strain. Expressed proteins were purified using Strep-Tactin XT purification system under native and denaturing conditions, as well as using detergents according to the optimized protocol for recombinant proteins solubilization from inclusion bodies. Among all expressed and purified proteins p32 and p54 were found to be immunoreactive and specific. Although p54 was unstable during long-term storage, after further storage condition optimization, the protein can be used for indirect ASF ELISA development. Recombinant p32 was shown to be an effective antigen for ASF ELISA providing detection of antibodies against ASFV with low background signal